Synthesis and evaluation of injectable, in situ crosslinkable synthetic extracellular matrices for tissue engineering.

Simple and effective biocompatible materials that mimic the natural extracellular matrix (ECM) were developed for a variety of uses in regenerative medicine. These synthetic ECMs (sECMs) were designed to recapitulate the minimal composition required to obtain functional ECMs. The sECM components are crosslinkable in situ, and may be seeded with cells prior to injection in vivo, without compromising either the cells or the recipient tissues. Several sECM compositions were evaluated to establish which formulation would be most beneficial for cell growth and tissue remodeling. Three natural ECM macromonomeric building blocks were employed: hyaluronan (HA), chondroitin sulfate (CS), and gelatin (Gtn). The carboxyl-rich glycosaminoglycans and Gtn were each chemically modified to give the corresponding thiolated dithiopropionylhydrazide (DTPH) derivatives (CS-DTPH, HA-DTPH, and Gtn-DTPH). Different compositions of CS-Gtn and HA-Gtn hydrogels were fabricated by crosslinking the thiolated biomacromonomers with polyethylene glycol diacrylate. Each sECM had high water content (>96%), biologically suitable mechanical properties, and a useful gelation time ( approximately 2-6 min). The bioerosion rates for the sECMs were determined, and a given composition could be selected to meet the requirements of a given clinical application. Both the HA-Gtn and CS-Gtn sECM hydrogels supported cell growth and proliferation with cultured murine fibroblasts in vitro. Moreover, subcutaneous injection of a suspension of murine fibroblasts in each of the two sECM hydrogels into nude mice in vivo resulted in the formation of viable and uniform soft tissue in vivo.

[1]  T. Matsuda,et al.  Tissue-engineered cartilage using an injectable and in situ gelable thermoresponsive gelatin: fabrication and in vitro performance. , 2003, Tissue engineering.

[2]  Fabio Palumbo,et al.  Disulfide-crosslinked hyaluronan-gelatin hydrogel films: a covalent mimic of the extracellular matrix for in vitro cell growth. , 2003, Biomaterials.

[3]  Wim E. Hennink,et al.  Novel crosslinking methods to design hydrogels , 2002 .

[4]  G. Prestwich,et al.  Synthesis and biological evaluation of a cross-linked hyaluronan-mitomycin C hydrogel. , 2004, Biomacromolecules.

[5]  A. Caplan,et al.  Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. , 1986, Developmental biology.

[6]  G. Prestwich,et al.  Biocompatibility and stability of disulfide-crosslinked hyaluronan films. , 2005, Biomaterials.

[7]  G. Prestwich,et al.  Composition of Hyaluronan Affects Wound Healing in the Rabbit Maxillary Sinus , 2006, American journal of rhinology.

[8]  J. Fraser,et al.  Hyaluronan: its nature, distribution, functions and turnover , 1997, Journal of internal medicine.

[9]  Glenn D Prestwich,et al.  Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor. , 2005, Biomaterials.

[10]  D. Mooney,et al.  Hydrogels for tissue engineering: scaffold design variables and applications. , 2003, Biomaterials.

[11]  Ralph Müller,et al.  Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.

[12]  J. Leroux,et al.  Novel injectable neutral solutions of chitosan form biodegradable gels in situ. , 2000, Biomaterials.

[13]  G. Prestwich,et al.  Disulfide-crosslinked hyaluronan-gelatin sponge: growth of fibrous tissue in vivo. , 2004, Journal of biomedical materials research. Part A.

[14]  D. Aeschlimann,et al.  New strategy for chemical modification of hyaluronic acid: preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. , 1999, Journal of biomedical materials research.

[15]  A. Mikos,et al.  Adhesion and migration of marrow-derived osteoblasts on injectable in situ crosslinkable poly(propylene fumarate-co-ethylene glycol)-based hydrogels with a covalently linked RGDS peptide. , 2003, Journal of biomedical materials research. Part A.

[16]  Jason A Burdick,et al.  Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. , 2002, Biomaterials.

[17]  K. Br,et al.  Current status of DNA vaccines in veterinary medicine. , 2000 .

[18]  Antonios G Mikos,et al.  Evaluation of thermal- and photo-crosslinked biodegradable poly(propylene fumarate)-based networks. , 2003, Journal of biomedical materials research. Part A.

[19]  J. Hubbell,et al.  Synthesis and physicochemical characterization of end-linked poly(ethylene glycol)-co-peptide hydrogels formed by Michael-type addition. , 2003, Biomacromolecules.

[20]  G. Prestwich,et al.  Crosslinked hyaluronan hydrogels containing mitomycin C reduce postoperative abdominal adhesions. , 2005, Fertility and sterility.

[21]  A. Mikos,et al.  Injectable biodegradable polymer composites based on poly(propylene fumarate) crosslinked with poly(ethylene glycol)-dimethacrylate. , 2000, Biomaterials.

[22]  J. Hubbell,et al.  Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. , 2001, Biomacromolecules.

[23]  D. A. French,et al.  In vivo evaluation and comparison of collagen, acetylated collagen and collagen/glycosaminoglycan composite films and sponges as candidate biomaterials. , 1990, Biomaterials.

[24]  Eben Alsberg,et al.  Engineering growing tissues , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Glenn D. Prestwich,et al.  In Vivo Engineering of the Vocal Fold Extracellular Matrix with Injectable Hyaluronic Acid Hydrogels: Early Effects on Tissue Repair and Biomechanics in a Rabbit Model , 2005, The Annals of otology, rhinology, and laryngology.

[26]  Allan S Hoffman,et al.  Hydrogels for biomedical applications. , 2002, Advanced drug delivery reviews.

[27]  H. Scheraga,et al.  Analysis for disulfide bonds in peptides and proteins. , 1987, Methods in enzymology.

[28]  E. Turley,et al.  HA receptors: Regulators of signalling to the cytoskeleton , 1996, Journal of cellular biochemistry.

[29]  W. Knudson,et al.  Cartilage proteoglycans. , 2001, Seminars in cell & developmental biology.

[30]  Glenn D Prestwich,et al.  Attachment and spreading of fibroblasts on an RGD peptide-modified injectable hyaluronan hydrogel. , 2004, Journal of biomedical materials research. Part A.

[31]  Andrew A. Pitsillides,et al.  An Essential Role for the Interaction Between Hyaluronan and Hyaluronan Binding Proteins During Joint Development , 1998, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  Glenn D Prestwich,et al.  Accelerated repair of cortical bone defects using a synthetic extracellular matrix to deliver human demineralized bone matrix , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[33]  J. Vacanti,et al.  Soft-Tissue Augmentation with Injectable Alginate and Syngeneic Fibroblasts , 2000, Plastic and reconstructive surgery.

[34]  K. Yoshizato,et al.  A new type of biomaterial for artificial skin: dehydrothermally cross-linked composites of fibrillar and denatured collagens. , 1993, Journal of biomedical materials research.

[35]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[36]  Glenn D Prestwich,et al.  Vocal fold tissue repair in vivo using a synthetic extracellular matrix. , 2006, Tissue engineering.

[37]  Y. M. Lee,et al.  Studies on gelatin-containing artificial skin: II. Preparation and characterization of cross-linked gelatin-hyaluronate sponge. , 1999, Journal of biomedical materials research.

[38]  P. Sinko,et al.  A hydrogel prepared by in situ cross-linking of a thiol-containing poly(ethylene glycol)-based copolymer: a new biomaterial for protein drug delivery. , 2003, Biomaterials.

[39]  T. Cruz,et al.  Receptor for hyaluronan-mediated motility (RHAMM), a hyaladherin that regulates cell responses to growth factors. , 1999, Biochemical Society transactions.

[40]  Glenn D Prestwich,et al.  Injectable synthetic extracellular matrices for tissue engineering and repair. , 2006, Advances in experimental medicine and biology.

[41]  A. Mikos,et al.  Injectable biodegradable materials for orthopedic tissue engineering. , 2000, Biomaterials.

[42]  David J Mooney,et al.  Synthetic extracellular matrices for tissue engineering and regeneration. , 2004, Current topics in developmental biology.

[43]  Glenn D Prestwich,et al.  In situ crosslinkable hyaluronan hydrogels for tissue engineering. , 2004, Biomaterials.

[44]  R Kujat,et al.  Engineering of osteochondral tissue with bone marrow mesenchymal progenitor cells in a derivatized hyaluronan-gelatin composite sponge. , 1999, Tissue engineering.

[45]  K. Healy,et al.  Thermo-responsive peptide-modified hydrogels for tissue regeneration. , 2001, Biomacromolecules.

[46]  J. Porter,et al.  A modification of the Ellman procedure for the estimation of protein sulfhydryl groups. , 1967, Archives of biochemistry and biophysics.

[47]  Glenn D Prestwich,et al.  Disulfide cross-linked hyaluronan hydrogels. , 2002, Biomacromolecules.

[48]  Antonios G Mikos,et al.  Development of an injectable, in situ crosslinkable, degradable polymeric carrier for osteogenic cell populations. Part 1. Encapsulation of marrow stromal osteoblasts in surface crosslinked gelatin microparticles. , 2002, Biomaterials.